The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2025 | Real-world validation of an AI-based score for lung cancer risk detection
Deniz Koksal, MD, Hacettepe University, Ankara, Türkiye, presents insights from the Phase I CREATE study (NCT05817110), which evaluated the use of artificial intelligence (AI) applied to chest X-rays for identifying high-risk lung nodules. The study compared an AI-derived lung nodule malignancy score (LNMS) with standard assessments on low-dose CT scans. The results showed strong concordance between the AI model and CT-based evaluations, highlighting the potential of AI-enhanced chest X-rays as a practical and accessible tool for lung cancer screening, particularly in resource-constrained settings. This interview took place at the European Lung Cancer Congress (ELCC) 2025 in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
